Search from website

SARS-CoV-2 Trimeric Spike B.1.621 (mu)

 

Figure 1. Simply Blue stained SDS-PAGE analysis of SARS-CoV-2 Trimeric Spike B.1.621. 4-12% gradient gel is used for analysis. Lane 1. 8 µg SARS-CoV-2 Trimeric Spike B.1.621 (-DTT). Lane 2. Protein marker (Smobio). Lane 3. 8 µg SARS-CoV-2 Trimeric Spike B.1.621 (+DTT).

       

Figure 2. HPLC analytical SEC for final product.

     

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

       

Figure 4. Octet Red96e analysis of SARS-CoV-2 Trimeric Spike B.1.621 binding to human ACE2 receptor.

     

Select volume:

Quantity:

€ 1950

Catalogue #

P-361-100

Name

SARS-CoV-2 Trimeric Spike B.1.621 (mu)

Uniprot ID

P0DTC2

MW

410.6

Host

CHO-based cell line (expressed by QMCF Technology)

Purification

Purified by Ni-affinity chromatography and gel-filtration from serum-free CHO growth media, sterile filtrated.

Purity

>95%

Concentration

1 mg/ml

Buffer

PBS pH 7.4

Endotoxine

NA

QC

SDS-PAGE, NanoDrop A280, Analytical SEC, Octet binding to ACE2

Shipping

Shipped on dry ice.

Storage

Store at -70°C upon receipt. Avoid repeated freeze-thaw cycles.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108
+1 415 548 6625

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
error:
Shopping Cart